documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
6 rows where docket_id = "FDA-2026-P-1833" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, open_for_comment, posted_date (date), comment_start_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2026-P-1833-0001 | FDA | None FDA-2026-P-1833 | Suitability Petition from Senores Pharmaceuticals, Inc. | Other | Petition(s) | 2026-02-19T05:00:00Z | 2026 | 2 | 2026-02-19T05:00:00Z | 2026-02-20T00:30:44Z | 1 | 0 | 09000064b91c14eb | ||
| FDA-2026-P-1833-0002 | FDA | None FDA-2026-P-1833 | Acknowledgement Letter from FDA DMB to Senores Pharmaceuticals, Inc. | Other | Acknowledgement Letter/Receipt | 2026-02-19T05:00:00Z | 2026 | 2 | 2026-02-19T05:00:00Z | 2026-02-20T00:30:48Z | 0 | 0 | 09000064b91c14f0 | ||
| FDA-2026-P-1833-0004 | FDA | None FDA-2026-P-1833 | Attachment 2 - Current Electronic Edition of the Approved Drug Products with Therapeutic Equivalence Evaluations - Tolmetin Sodium | Supporting & Related Material | Background Material | 2026-02-19T05:00:00Z | 2026 | 2 | 2026-02-20T00:31:03Z | 0 | 0 | 09000064b91bf195 | |||
| FDA-2026-P-1833-0003 | FDA | None FDA-2026-P-1833 | Attachment 1 - Current Electronic Edition of the Approved Drug Products with Therapeutic Equivalence Evaluations | Supporting & Related Material | Background Material | 2026-02-19T05:00:00Z | 2026 | 2 | 2026-02-20T00:31:00Z | 0 | 0 | 09000064b91bf194 | |||
| FDA-2026-P-1833-0005 | FDA | None FDA-2026-P-1833 | Attachment 3 - Prescribing Information Tolmetin Sodium Capsules USP 400 mg | Supporting & Related Material | Background Material | 2026-02-19T05:00:00Z | 2026 | 2 | 2026-02-20T00:31:07Z | 0 | 0 | 09000064b91bf196 | |||
| FDA-2026-P-1833-0006 | FDA | None FDA-2026-P-1833 | Attachment 4 - Proposed labeling for Tolmetin Sodium Capsules 600 mg | Supporting & Related Material | Background Material | 2026-02-19T05:00:00Z | 2026 | 2 | 2026-02-20T00:31:10Z | 0 | 0 | 09000064b91bf197 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;